Prudential Financial
VRNA

Prudential Financial’s Verona Pharma VRNA Stock Holding History

Prudential Financial’s Portfolio VRNA Stock Details VRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-179,200
Closed -$16.9M – 2536
2025
Q2 		$16.9M Buy
179,200
+39,200
+28% +$2.9M 0.02% 463
2025
Q1 		$8.89M Sell
140,000
-68,100
-33% -$4.07M 0.01% 633
2024
Q4 		$9.66M Buy
208,100
+31,432
+18% +$1.18M 0.01% 624
2024
Q3 		$5.08M Sell
176,668
-88
-0% -$2.17K 0.01% 982
2024
Q2 		$2.56M Hold
176,756
– – ﹤0.01% 1288
2024
Q1 		$2.84M Buy
176,756
+33,985
+24% +$588K ﹤0.01% 1239
2023
Q4 		$2.84M Buy
142,771
+22
+0% +$325 ﹤0.01% 1216
2023
Q3 		$2.36M Hold
142,749
– – ﹤0.01% 1266
2023
Q2 		$3.02M Sell
142,749
-6,409
-4% -$137K ﹤0.01% 1177
2023
Q1 		$3M Buy
149,158
+9,113
+7% +$197K ﹤0.01% 1092
2022
Q4 		$3.66M Buy
+140,045
New +$1.86M 0.01% 1010

Other funds holding VRNA

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Prudential Financial's VRNA Position: Q3 2025 in Review

Prudential Financial sold out of Verona Pharma (VRNA) in Q3 2025, closing a stake of 179,200 shares — an estimated $16.9M sold.

Prudential Financial first reported a position in VRNA in Q4 2022 and held it in 11 quarters. The position peaked at $16.9M in Q2 2025. 243 funds tracked by Wall St. Rank hold VRNA as of Q3 2025.

  • Prudential Financial reported no remaining Verona Pharma position as of Q3 2025 after selling out during the quarter.
  • Prudential Financial sold 179,200 Verona Pharma shares in Q3 2025, an estimated $16.9M.
  • Prudential Financial first reported a position in Verona Pharma in Q4 2022 and held it in 11 quarters.
  • Prudential Financial's Verona Pharma position peaked at $16.9M in Q2 2025.
  • 243 funds tracked by Wall St. Rank held Verona Pharma as of Q3 2025.

Based on Prudential Financial's 13F filing for Q3 2025, filed 13 Nov 2025.